Talzenna
Product Images NDC 63539-051

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Talzenna (NDC 63539-051). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by U.s. Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Talzenna 01)

Chemical structure diagram showing the molecular components of Talzenna (1 mg), illustrating the key rings and functional groups of the active pharmaceutical ingredient along with an associated molecular variant with sulfonic acid group.*

FDA Label Image

Figure 1 (Talzenna 02)

A Kaplan-Meier curve showing progression-free survival probability (%) over time in months, comparing Talzenna to chemotherapy. The graph includes a table of the number of patients at risk for each treatment group at various time points up to 36 months. Talzenna shows higher progression-free survival probability than chemotherapy throughout the study period.*

FDA Label Image

Talzenna 02a

A Kaplan-Meier survival curve comparing overall survival probability over time in months between Talzenna and chemotherapy. The graph shows survival rates declining from 100% to below 20% over a 60-month period, with patient risk counts listed below for both treatments.*

FDA Label Image

Logo (Talzenna 03)

FDA Label Image

Logo (Talzenna 04)

FDA Label Image

Principal Display Panel (1 mg Capsule Bottle Label)

Label for Talzenna 1 mg capsules containing talazoparib, distributed by U.S. Pharmaceuticals, Pfizer Inc. The label shows storage instructions, dosage notice, and a 30-capsule count. It also includes a barcode, NDC 63539-295-30, and indicates the product is prescription only and a professional sample not for sale.*

FDA Label Image

Principal Display Panel (1 mg Capsule Bottle Carton)

Packaging label for Talzenna 1 mg capsules by U.S. Pharmaceuticals under Pfizer. The label states Talzenna (talazoparib) capsules, prescription only, with a quantity of 30 capsules. Storage instructions specify 20°C to 25°C with permitted excursions. The label includes dosage information referencing accompanying prescribing information, manufacture in Germany, and distribution details by U.S. Pharmaceuticals, Pfizer Inc., New York, NY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.